Stock VLG VENTURE LIFE GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Venture Life Group plc

Equities

VLG

GB00BFPM8908

Pharmaceuticals

Market Closed - London S.E.
Other stock markets
 11:35:20 2024-04-26 am EDT 		5-day change 1st Jan Change
41.5 GBX -1.78% Intraday chart for Venture Life Group plc +6.41% +23.88%
Apr. 19 Venture Life renews revolving credit facility with Santander and HSBC AN
Apr. 19 Venture Life Group plc Renews Revolving Credit Facility with Santander UK PLC and HSBC Innovation Bank Limited CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 36.83 28.04 117 37.75 46.17 52.5 52.5 -
Enterprise Value (EV) 1 31.03 24.36 86.11 45.24 62.47 42.38 61.67 53.43
P/E ratio 116 x 33.2 x 36.8 x 16.8 x 93.6 x 49.3 x 22.6 x 12.6 x
Yield - - - - - - - -
Capitalization / Revenue 1.96 x 1.39 x 3.89 x 1.15 x 1.05 x 0.82 x 0.95 x 0.89 x
EV / Revenue 1.65 x 1.21 x 2.86 x 1.38 x 1.42 x 0.82 x 1.12 x 0.91 x
EV / EBITDA 12.8 x 9.22 x 15.5 x 7.06 x 7.03 x 3.67 x 5.27 x 3.89 x
EV / FCF -940 x - 59.1 x 197 x 13.3 x 9.26 x 10 x 8.67 x
FCF Yield -0.11% - 1.69% 0.51% 7.53% 10.8% 9.95% 11.5%
Price to Book - - 1.62 x 0.52 x 0.61 x 0.68 x 0.66 x 0.59 x
Nbr of stocks (in thousands) 83,712 83,712 125,832 125,832 126,498 126,498 126,498 -
Reference price 2 0.4400 0.3350 0.9300 0.3000 0.3650 0.4150 0.4150 0.4150
Announcement Date 4/18/19 4/9/20 3/25/21 5/17/22 4/4/23 4/9/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 18.77 20.21 30.08 32.76 43.98 51.41 55.02 58.96
EBITDA 1 2.432 2.643 5.545 6.404 8.89 11.56 11.69 13.72
EBIT 1 1.051 1.278 3.555 1.371 3.505 3.289 4.68 7.974
Operating Margin 5.6% 6.32% 11.82% 4.18% 7.97% 6.4% 8.51% 13.52%
Earnings before Tax (EBT) 1 0.71 1.362 3.276 0.946 0.706 1.123 3.08 5.534
Net income 1 0.236 0.904 2.368 2.402 0.52 0.921 2.495 4.483
Net margin 1.26% 4.47% 7.87% 7.33% 1.18% 1.79% 4.53% 7.6%
EPS 2 0.003800 0.0101 0.0253 0.0179 0.003900 0.006800 0.0184 0.0330
Free Cash Flow 1 -0.033 - 1.458 0.23 4.706 6.8 6.138 6.162
FCF margin -0.18% - 4.85% 0.7% 10.7% 13.43% 11.16% 10.45%
FCF Conversion (EBITDA) - - 26.29% 3.59% 52.94% 58.62% 52.49% 44.92%
FCF Conversion (Net income) - - 61.57% 9.58% 905% 400% 246.01% 137.45%
Dividend per Share - - - - - - - -
Announcement Date 4/18/19 4/9/20 3/25/21 5/17/22 4/4/23 4/9/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2022 S1 2023 S1
Net sales 16.9 18.86 -
EBITDA 3.163 - -
EBIT 2.28 - -
Operating Margin 13.49% - -
Earnings before Tax (EBT) - - -
Net income 1 - - -1.508
Net margin - - -
EPS 2 - - -0.0119
Dividend per Share - - -
Announcement Date 9/24/20 9/22/22 9/25/23
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - 7.49 16.3 10.5 9.17 0.94
Net Cash position 1 5.8 3.69 30.9 - - - - -
Leverage (Debt/EBITDA) - - - 1.17 x 1.834 x 0.9022 x 0.7842 x 0.0682 x
Free Cash Flow 1 -0.03 - 1.46 0.23 4.71 6.8 6.14 6.16
ROE (net income / shareholders' equity) - - - - - 9.5% 9.4% 11.2%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - 0.5700 0.5800 0.6000 0.6100 0.6300 0.7000
Cash Flow per Share - 0.0300 - - - - - -
Capex 1 0.27 0.39 1.25 0.37 0.86 1.8 2.8 2.26
Capex / Sales 1.44% 1.92% 4.15% 1.13% 1.96% 3.56% 5.09% 3.83%
Announcement Date 4/18/19 4/9/20 3/25/21 5/17/22 4/4/23 4/9/24 - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Venture Life Group plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.415 GBP
Average target price
0.76 GBP
Spread / Average Target
+83.13%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
VENTURE LIFE GROUP PLC Stock Venture Life Group plc
+23.88% 65.39M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VLG Stock
  4. Financials Venture Life Group plc